These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 23499279)

  • 1. Usefulness of frequent supraventricular extrasystoles and a high CHADS2 score to predict first-time appearance of atrial fibrillation.
    Suzuki S; Sagara K; Otsuka T; Kano H; Matsuno S; Takai H; Uejima T; Oikawa Y; Koike A; Nagashima K; Kirigaya H; Yajima J; Tanabe H; Sawada H; Aizawa T; Yamashita T
    Am J Cardiol; 2013 Jun; 111(11):1602-7. PubMed ID: 23499279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of a Combination of Interatrial Block and a High CHADS2 Score to Predict New Onset Atrial Fibrillation.
    Wu JT; Wang SL; Chu YJ; Long DY; Dong JZ; Fan XW; Yang HT; Duan HY; Yan LJ; Qian P; Yang CK
    Int Heart J; 2016 Sep; 57(5):580-5. PubMed ID: 27593538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
    Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY
    Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
    Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A
    Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHADS₂, CHA₂S₂DS₂-VASc, and long-term stroke outcome in patients without atrial fibrillation.
    Ntaios G; Lip GY; Makaritsis K; Papavasileiou V; Vemmou A; Koroboki E; Savvari P; Manios E; Milionis H; Vemmos K
    Neurology; 2013 Mar; 80(11):1009-17. PubMed ID: 23408865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of CHADS2 score to predict C-reactive protein, left atrial blood stasis, and prognosis in patients with nonrheumatic atrial fibrillation.
    Maehama T; Okura H; Imai K; Yamada R; Obase K; Saito K; Hayashida A; Neishi Y; Kawamoto T; Yoshida K
    Am J Cardiol; 2010 Aug; 106(4):535-8. PubMed ID: 20691312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHADS2 score and risk of new-onset atrial fibrillation: a nationwide cohort study in Taiwan.
    Chao TF; Liu CJ; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Wu TJ; Chen TJ; Chen SA
    Int J Cardiol; 2013 Sep; 168(2):1360-3. PubMed ID: 23280330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
    Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
    Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supraventricular arrhythmia, N-terminal pro-brain natriuretic peptide and troponin T concentration in relation to incidence of atrial fibrillation: a prospective cohort study.
    Xiao J; Persson AP; Engström G; Johnson LSB
    BMC Cardiovasc Disord; 2021 Mar; 21(1):134. PubMed ID: 33711943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of CHADS2, CHA2DS2-VASc, and R2CHADS2 scores with left atrial dysfunction in patients with coronary heart disease (from the Heart and Soul study).
    Azarbal F; Welles CC; Wong JM; Whooley MA; Schiller NB; Turakhia MP
    Am J Cardiol; 2014 Apr; 113(7):1166-72. PubMed ID: 24507169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events.
    Botto GL; Padeletti L; Santini M; Capucci A; Gulizia M; Zolezzi F; Favale S; Molon G; Ricci R; Biffi M; Russo G; Vimercati M; Corbucci G; Boriani G
    J Cardiovasc Electrophysiol; 2009 Mar; 20(3):241-8. PubMed ID: 19175849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of new onset atrial fibrillation during 10-year follow-up after first-ever ischemic stroke.
    Baturova MA; Lindgren A; Carlson J; Shubik YV; Olsson SB; Platonov PG
    Int J Cardiol; 2015 Nov; 199():248-52. PubMed ID: 26209828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of previously undiagnosed atrial fibrillation in patients with stroke risk factors and usefulness of continuous monitoring in primary stroke prevention.
    Ziegler PD; Glotzer TV; Daoud EG; Singer DE; Ezekowitz MD; Hoyt RH; Koehler JL; Coles J; Wyse DG
    Am J Cardiol; 2012 Nov; 110(9):1309-14. PubMed ID: 22819433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of supraventricular activity and incidence of atrial fibrillation.
    Johnson LS; Juhlin T; Juul-Möller S; Hedblad B; Nilsson PM; Engström G
    Heart Rhythm; 2015 Sep; 12(9):1898-904. PubMed ID: 25956964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CHADS
    Kondo T; Yamada T; Morita T; Furukawa Y; Tamaki S; Iwasaki Y; Kawasaki M; Kikuchi A; Kawai T; Takahashi S; Ishimi M; Hakui H; Ozaki T; Sato Y; Seo M; Sakata Y; Fukunami M
    Heart Vessels; 2017 Feb; 32(2):193-200. PubMed ID: 27325225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study.
    Potpara TS; Polovina MM; Marinkovic JM; Lip GY
    Int J Cardiol; 2013 Oct; 168(5):4744-9. PubMed ID: 23958417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial fibrillation significantly increases total mortality and stroke risk beyond that conveyed by the CHADS2 risk factors.
    Crandall MA; Horne BD; Day JD; Anderson JL; Muhlestein JB; Crandall BG; Weiss JP; Osborne JS; Lappé DL; Bunch TJ
    Pacing Clin Electrophysiol; 2009 Aug; 32(8):981-6. PubMed ID: 19659615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate of antithrombotic drug use and clinical outcomes according to CHADS2 scores in patients with an initial cardioembolic stroke who had nonvalvular atrial fibrillation.
    Deguchi I; Ogawa H; Ohe Y; Nemoto M; Tanahashi N
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):846-50. PubMed ID: 22819543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of the CHADS2 and CHA2DS2-VASc scores in post-myocardial infarction patients: Risk of new occurrence of atrial fibrillation and ischemic stroke.
    Lau KK; Chan PH; Yiu KH; Chan YH; Liu S; Chan KH; Yeung CY; Li SW; Tse HF; Siu CW
    Cardiol J; 2014; 21(5):474-83. PubMed ID: 24846512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent Atrial Premature Complexes and Their Association With Risk of Atrial Fibrillation.
    Acharya T; Tringali S; Bhullar M; Nalbandyan M; Ilineni VK; Carbajal E; Deedwania P
    Am J Cardiol; 2015 Dec; 116(12):1852-7. PubMed ID: 26611122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.